{"text": "gild top analyst price target for next week"}
{"text": "datopotamab deruxtecan showed encouraging amp durable efficacy in patients with heavily pretreated hr her2 low neg metastatic breast cancer daiichi azn orr 27 mpfs 8 3mo 12mo os 59 looks competitive vs gild tropics 02 on orr amp pfs aligned on os"}
{"text": "gild kite pharma and daiichi sankyo amending the licensing agreement covering the yescarta therapy for cancer in japan"}
{"text": "this slide also suggests that lonarfanib ifn can be a great tool to get acute hepatitis flares quickly under control resulting in less damage fibrosis progression to liver not a chronic treatment but for treating flares eigr gild hdv"}
{"text": "news lifesciences financialmarkets somewhatbullish gild 2022 12 09 06 33 here s how much you would have made owning gilead sc"}
{"text": "gild highest 52w close now over 89 heading to 100s"}
